Impact of Preoxygenation Time on End-tidal Oxygen Concentration and on Hypoxic Events Occurring After Intubation in the Intensive Care Unit.
Launched by CENTRE HOSPITALIER RÉGIONAL D'ORLÉANS · Oct 31, 2019
Trial Information
Current as of August 02, 2025
Withdrawn
Keywords
ClinConnect Summary
This is a multicenter randomized controlled pilot study. 110 patients who require intubation in the ICU will be randomly assigned, with a 1:1 ratio, to 3 or 5 minutes of preoxygenation duration. EtO2 will be continuously measured but hidden to the clinician. The primary outcome measure will be the obtention of an optimal preoxygenation defined by an EtO2 \>90%. Secondary outcomes include the occurrence of hypoxia and complications during the procedure.
A pulse oximetry (SpO2) greater than or equal to 96% (SpO2 ≥ 96%) at the end of preoxygenation will be the target in each group. If at the ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 18 years
- • Requiring intubation in ICU
- • Free express oral and informed consent of the patient or a proxy in case of impossibility for the patient to consent; emergency inclusion possible when legal representatives and patient's family are not present
- Exclusion Criteria:
- • Intubation for cardiac arrest
- • End-tidal oxygen concentration monitoring not available
- • Preoxygenation with high-flow nasal oxygenation
- • Previous participation to the study
- • Patient known, at time of inclusion, as being under guardianship, tutorship or curator
- • Pregnancy or breastfeeding
- • Lack of social security number
About Centre Hospitalier Régional D'orléans
The Centre Hospitalier Régional d'Orléans is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Orléans, France, the center is committed to fostering a collaborative environment that integrates clinical expertise with cutting-edge research methodologies. By facilitating multidisciplinary studies across various therapeutic areas, the Centre Hospitalier Régional d'Orléans aims to enhance treatment protocols and contribute to the global body of medical knowledge, ultimately benefiting patients and the healthcare community at large.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tours, , France
Dax, , France
Orléans, , France
Patients applied
Trial Officials
Mai-ANh NAY, MD
Principal Investigator
CHR Orléans
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials